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A B S T R A C T
Background: Previous epidemiological studies, largely conducted in high-income countries and cross-sectional,
have suggested a relatively strong association between exposure to dichlorodiphenyldichloroethylene (DDE), a
metabolite of the pesticide dichlorodiphenyltrichloroethane (DDT), and type 2 diabetes. DDT is widely used in
India and the prevalence of type 2 diabetes there is increasing, but the association between these factors has not
been explored to date.
Objective: The objective was to estimate the association of the p,p′ isomer of DDE with incident type 2 diabetes in
India.
Methods: A nested case-control study was conducted in a representative prospective cohort of adults from two
cities in India. Participants were enrolled in 2010–11 (n=12,271) and followed for annual assessment of
chronic diseases including type 2 diabetes. Baseline plasma samples from incident cases of diabetes (n=193)
and sex-city-matched controls (n=323) were selected for analysis of p,p-DDE. Odds ratios (OR) and 95%
confidence intervals (CI) were estimated using conditional logistic regression.
Results: At baseline, cases had higher p,p-DDE concentrations: geometric mean (95% CI) 330 (273–399) ng/g
lipid compared to 223 (189–262) ng/g lipid among controls. Delhi participants had higher p,p-DDE con-
centrations: 579 (521–643) ng/g lipid compared to 122 (102–145) ng/g lipid in Chennai. In unadjusted models,
being in the highest versus lowest quartile of p,p-DDE was associated with a more than doubling of the odds of
diabetes: unadjusted OR (95% CI), 2.30 (1.19, 4.43). However, this effect was no longer significant after ad-
justment for age: adjusted (95% CI), 0.97 (0.46, 2.06).
Discussion: Results suggest that levels of p,p′-DDE in Delhi are exceptionally high, but we did not observe a
significant association between p,p-DDE and incident type 2 diabetes. As this is the first study to evaluate this
association in India, more studies are needed to inform our understanding of the association in this context,
including potential routes of exposure.
1. Introduction
The number of people with diabetes in India increased by nearly
two-fold from 2007 to 2017 (International Diabetes Federation, 2017).
Nationally, the prevalence of diabetes is high, especially in middle and
old age, across all states and sociodemographic groups (Geldsetzer
et al., 2018). Previous studies have documented the important role of
aging and changes in lifestyle behaviours in this epidemic, but few have
explored other potential risk factors such as endocrine disrupting che-
micals (EDCs).
Dichlorodiphenyltrichloroethane (DDT) and its metabolite, di-
chlorodiphenyldichloroethylene (DDE), have been implicated as potent
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EDCs, and India is the only country that continues to produce DDT (Van
Den Berg et al., 2017). The Endocrine Society's most recent Scientific
Statement on EDCs concluded that the role of organochlorine pesticides
such as DDT in the incidence of type 2 diabetes “currently represents
the most solid association between a class of EDCs and the increase in
the prevalence of type 2 diabetes” (Gore et al., 2015). A meta-analysis
of 14 studies conducted through 2015 on the association between DDE
and type 2 diabetes reported a summary odds ratio (OR) (95% con-
fidence interval [CI]) of 1.95 (1.44, 2.66) (Evangelou et al., 2016),
compared to, for example, a summary relative risk (95% CI) of 1.30
(1.20, 1.40) comparing high versus low intake of sugar sweetened
beverages in 10 studies (Schwingshackl et al., 2017).
All of the 14 studies included in that meta-analysis were conducted
in high-income countries, largely in North America and Europe, and
most were cross-sectional (Evangelou et al., 2016). Given that type 2
diabetes is a chronic disease that develops over the course of several
years (Martin et al., 1992), and that adipose compartment dynamics
(i.e., weight gain or weight loss) may influence the levels of DDE in
circulation (Wolff et al., 2007), prospective studies are critical for
providing more conclusive evidence on this association. The objective
of this study was to estimate the association of DDE measured in human
plasma with incident type 2 diabetes using a nested case-control study
design in a prospective cohort of adults from urban India.
2. Methods
2.1. Study population and sample collection
Centre for cArdiometabolic Risk Reduction in South-Asia (CARRS) is
a prospective cohort study, established in 2010–11, when 12,271 men
and non-pregnant women aged 20 years and above were enrolled in
Delhi and Chennai, India (Nair et al., 2012). Fasting venous blood
samples were collected for clinical biomarker assessment and bio-
banking. Specifically, 5 ml of venous blood was collected into a la-
vender-top Vacutainer tube containing EDTA and transported in coolers
on ice packs to a facility where they were centrifuged for 15min at
3500 rpm. Then 0.5ml-aliquots of plasma were prepared in 1.0 ml
cryovials and stored at −80 °C. For this ancillary study, plasma samples
from baseline were pulled from storage and shipped on dry ice to the
School of Environmental Sciences at Jawaharlal Nehru University for
sample extraction.
After the baseline study visit, participants were contacted annually
to collect information on self-reported diagnoses of chronic diseases
including type 2 diabetes, and additional venous blood samples were
collected for testing of clinical biomarkers at the second and fourth
follow-up visits (2013 and 2015). Fasting plasma glucose (FPG) was
measured using the hexokinase/kinetic method and glycated he-
moglobin A1c (HbA1c) using high-performance liquid chromatography.
Participants with non-missing data for FPG and HbA1c at the baseline
and second follow-up visit (n= 7140) were eligible for inclusion in this
ancillary study (Fig. 1).
This CARRS ancillary study was approved by the ethics review
committees at Harvard University (IRB16–1092), Emory University
(IRB00044159), and the Public Health Foundation of India (TRC-IEC-
236/14). Written informed consent was obtained from all participants
at baseline to use stored blood samples for “further laboratory tests for
medical research.”
2.2. Case and control definition
Incident type 2 diabetes was defined as having FPG<126mg/dl,
HbA1c< 6.5%, and no self-reported physician-diagnosed diabetes at
baseline (2010−11), and FPG ≥126mg/dl, HbA1c ≥6.5%, or self-
reported physician-diagnosed diabetes at one or more of the follow up
visits (2012–15) (American Diabetes Association, 2017). Controls were
defined as having all of the following at both baseline and throughout
the follow-up period: FPG<100mg/dl, HbA1c< 5.7%, and no self-
reported physician-diagnosed diabetes.
A total of 193 participants met the case definition from Delhi and
Chennai and had sufficient plasma sample (at least 500 μL) available for
laboratory analysis of DDE. Controls were matched to cases 2:1 on sex
(male or female) and city (Delhi or Chennai). Out of 104 total cases in
Delhi, there were 30 male cases and 33 female cases that could not be
matched to 2 controls and were matched 1:1. In sum, there were 130
case-control pairs matched 2:1 and 63 case-control pairs matched 1:1.
2.3. Biomarker analysis
Analysis of DDE focused on the p,p′ isomer (p,p-DDE). Plasma
samples (17 participant samples), reagent and matrix blanks, and
National Institute of Standards and Technology (NIST) Standard
Reference Materials (SRMs 1958) were analysed concurrently in each
run using a modification of existing methods (Marder et al., 2016;
Gaspar et al., 2017). All samples (500 μL) were spiked with 1 ng of ring-
labelled 13C12-p,p-DDE as an internal standard. 2ml of formic acid
(50% v/v) was added to each sample to denature plasma proteins, then
the samples were extracted twice with 5ml of hexane. The hexane
extracts were loaded onto the ISOLUTE Florisil cartridges topped with
0.5 g of anhydrous sodium sulfate and 1.8 g of acidified silica to remove
residual biogenic materials, particularly lipids. The cartridges were
Fig. 1. Flow chart of participant inclusion in this nested case-control study
conducted in a representative prospective cohort of adults.
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eluted with hexane:dichloromethane (19:1 v/v). Extracts were evapo-
rated to dryness, reconstituted with 50 μL of nonane, and analysed
using gas chromatography-tandem mass spectrometry.
The mass spectrometer was operated using electron ionisation
technique. The target analytes (p,p′-DDE and its labelled analog) were
monitored using multi-reaction monitoring mode. The concentration of
the target analyte was determined from the peak ratio of analyte to
labelled standard in the sample, by comparison to the standard cali-
bration curve. The certified calibrants were obtained from Cambridge
Isotope Laboratories (Tewksbury, Massachusetts, USA). Quality assur-
ance and quality control parameters included the use of NIST SRMs and
blanks.
2.4. Covariate assessment
Sociodemographic characteristics including age, sex, educational
attainment, occupational status, and monthly household income, as
well as behavioural risk factors including tobacco and alcohol use, and
dietary intake were assessed by a questionnaire developed based on
questions used in previous studies (Nair et al., 2012; Iqbal et al., 2008).
In particular, for dietary intake, a 26-item food propensity ques-
tionnaire adapted from the INTERHEART study (Iqbal et al., 2008) was
used, which queried the frequency of consumption (never or less than
once a month, per month, per week, or per day) over the past year.
Thirteen food groups were evaluated: meat, poultry, seafood, eggs,
dairy, vegetables, fruit, legumes, nuts, whole grains, refined grains,
fried foods, and desserts.
Trained enumerators used standardised procedures to measure
weight to the nearest 0.1 kg, height to the nearest 0.1 cm, and waist and
hip circumferences to the nearest 0.1 cm based on the U.S. National
Health and Nutrition Examination Survey protocol (Centers for Disease
Control and Prevention, 1988). Body mass index (BMI) was calculated
as weight (kg) divided by height-squared (m2). BMI was categorised as
normal weight (BMI<25 kg/m2), overweight (BMI 25 -< 30 kg/m2),
and obesity (BMI ≥30 kg/m2). Urinary albumin was measured using an
immunoturbidimetric assay and urinary and serum creatinine were
measured using the kinetic Jaffe method with isotope dilution mass
spectrometry traceable assays (Roche Diagnostics, Manheim, Ger-
many). We defined chronic kidney disease as an albumin-to-creatinine
ratio ≥30mg/g or estimated glomerular filtration rate< 60ml/min/
1.73m2 at baseline or the second or fourth follow-up visits (Anand
et al., 2015; Eknoyan et al., 2013). The Chronic Kidney Disease Epi-
demiology Collaboration equation was used to estimate glomerular
filtration rate (Levey et al., 2009).
Total cholesterol was measured in fasting serum samples using the
cholesterol oxidase peroxidase timed-endpoint method, triglycerides
were measured using the glycerol-3-phosphate oxidase enzymatic col-
orimetric method, and high-density lipoprotein (HDL) cholesterol was
measured directly. Low-density lipoprotein (LDL) cholesterol was cal-
culated using the Friedewald equation (Friedewald et al., 1972). Total
serum lipid content was calculated using the Phillips formula (Phillips
et al., 1989). Lipid-adjusted p,p-DDE concentrations (ng/g lipid) were
used in the analysis.
2.5. Statistical analysis
Descriptive statistics were used to summarise the sociodemographic
and clinical characteristics, behavioural risk factors (tobacco and al-
cohol use and dietary intake [13 food groups]), and p,p-DDE con-
centration of cases and controls at baseline. Given that the distribution
of p,p-DDE was highly skewed (kurtosis in overall sample of 23.62
where a normally distributed variable would have a kurtosis near zero),
we report geometric means (95% confidence intervals [CI]) throughout.
In order to determine the final confounder adjustment set (Rothman
et al., 2008), we then analysed the association of these characteristics
with quartiles of p,p-DDE among controls using descriptive statistics
and Chi-square tests for binary and categorical variables or Kruskal-
Wallis tests for continuous variables. We also evaluated the association
between dietary intake and p,p-DDE among controls using multi-
variable linear regression, adjusting for city, sex, and age because we
have previously reported that these three factors are important pre-
dictors of dietary intake in this cohort (Jaacks et al., 2016).
Given that the relationship between p,p-DDE and type 2 diabetes is
likely non-monotonic (Lee, 2014), in order to estimate the association
between p,p-DDE and incident type 2 diabetes we categorised p,p-DDE
into quartiles according to the lipid-adjusted distribution among the
controls. OR and 95% CI were estimated using conditional logistic re-
gression (Hosmer and Lemeshow, 2000). Progressive degrees of multi-
variable adjustment were implemented: (1) crude model; (2) model
adjusted for sociodemographic characteristics that were significantly
associated with p,p-DDE among the controls; (3) model adjusted for all
of the variables in (2) as well as waist circumference; and (4) model
adjusted for all of the variables in (3) as well as FPG. This final ad-
justment was made because cases and controls differed in levels of FPG
at baseline with cases having higher mean FPG (though still below the
threshold for type 2 diabetes).
Sensitivity analyses were conducted that specified log-transformed
p,p-DDE continuously as wet weight and two different approaches to
accounting for blood lipid concentration: lipid-adjusted values (ng/g
lipid) and wet weight adjusting for total lipid as a separate variable in
multivariable models. We also formally evaluated the interaction be-
tween age and p,p-DDE in these models, and estimated models stratified
by baseline BMI status (BMI< 25 kg/m2 versus ≥25 kg/m2) and city
(Chennai versus Delhi). In an additional series of sensitivity analyses,
we used linear regression to estimate the effect of lipid-adjusted p,p-
DDE (ng/g lipid) on the continuous outcomes of FPG and HbA1c at the
second follow-up visit, stratified by case-control status, with pro-
gressive degrees of multivariable adjustment as described above.
Finally, we compared p,p-DDE levels among cases with and without
chronic kidney disease in an exploratory analysis.
Analyses were conducted using SAS v.9.4 (SAS Institute Inc., Cary,
North Carolina, USA).
3. Results
Type 2 diabetes cases were older (mean 43.7 years versus 35.9 years
in controls), were more likely to have a monthly household income>
20,000 INR (~$280 USD), were more likely to have a family history of
diabetes, and had lower dietary intakes of refined grains compared to
controls at baseline (Table 1). Cases also had higher levels of BMI, waist
circumference, FPG, and HbA1c.
The geometric mean (95% CI) concentration of p,p-DDE among all
516 participants was 258.10 (227.71, 292.54) ng/g lipid with a max-
imum reported value of 6612.99 ng/g lipid. At baseline, cases had
higher p,p-DDE concentrations: geometric mean (95% CI) of 329.96
(272.91, 398.94) ng/g lipid compared to 222.87 (189.25, 262.46) ng/g
lipid among controls. Participants living in Delhi also had higher p,p-
DDE concentrations: geometric mean (95% CI) of 578.96 (521.05,
643.31) ng/g lipid compared to 121.50 (101.55, 145.37) ng/g lipid
among participants living in Chennai.
With respect to covariate associations, controls in the highest
quartile of p,p-DDE were more likely to be from Delhi, male, working,
to have a monthly household income>20,000 INR, and to have ever
used tobacco products (Table 2). Controls in the highest quartile of p,p-
DDE also had higher waist circumferences and FPG at baseline. Adults
in quartile 1 of p,p-DDE had higher dairy and fruit intakes compared to
the referent (lowest) quartile of p,p-DDE, but no association was ob-
served for either food group in higher quartiles of p,p-DDE (Supple-
mentary Materials, pp. 1–3).
In unadjusted models, being in the highest versus lowest quartile of
p,p-DDE was associated with a more than doubling of the odds of
diabetes: unadjusted OR (95% CI), 2.30 (1.19, 4.43) (Table 3).
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However, this effect was no longer significant after adjustment for so-
ciodemographic characteristics (age, occupational status, monthly
household income, and tobacco use): adjusted OR (95% CI), 0.94 (0.51,
1.74). Further adjustment for waist circumference and FPG did not
substantially change the effect estimate: adjusted OR (95% CI), 0.87
(0.30, 2.55). When each covariate was included in the model in-
dividually (Supplementary Materials, p. 5), age was identified as the
strongest confounder: with adjustment for age alone, the OR (95% CI)
was 0.97 (0.46, 2.06).
Results were consistent in sensitivity analyses modelling wet weight
p,p-DDE (e.g., with no adjustment for total blood lipid content):
unadjusted OR (95% CI), 1.34 (1.12, 1.60) and OR (95% CI) adjusted
for the same set of sociodemographic characteristics (age, occupational
status, monthly household income, and tobacco use), 1.06 (0.88, 1.26).
Similarly, results were robust to modelling lipid-adjusted p,p-DDE
concentrations continuously (log-transformed ng/g lipid): unadjusted
OR (95% CI), 1.23 (1.03, 1.46) and OR (95% CI) adjusted for the same
set of sociodemographic characteristics, 0.99 (0.83, 1.18). Adjusting for
total blood lipid content as a separate variable did not substantially
change the findings: OR (95% CI) adjusted for total blood lipid content,
1.16 (0.97, 1.39) and OR (95% CI) adjusted for total blood lipid content
and the same set of sociodemographic characteristics, 0.97 (0.81, 1.17).
The interaction term for p,p-DDE and age was non-significant
(p= 0.80 in unadjusted models and p=0.71 in models additionally
adjusted for occupational status, monthly household income, and to-
bacco use), and thus was not included in the final adjustment set. In
models stratified by baseline BMI status, the OR (95% CI) adjusted for
sociodemographic characteristics comparing the highest and lowest
quartile of p,p-DDE was of greater magnitude among those with over-
weight/obesity (1.34 [0.23, 7.88]) than among those who were normal
weight (0.59 [0.08, 4.34]). In models stratified by city, the uncondi-
tional logistic regression OR (95% CI) adjusted for sex and socio-
demographic characteristics (age, occupational status, monthly house-
hold income, and tobacco use) for lipid-adjusted p,p-DDE
concentrations (log-transformed ng/g lipid) was 0.97 (0.80, 1.17) in
Chennai and 1.32 (0.89, 1.97) in Delhi. In linear regression models
estimating the effect of baseline lipid-adjusted p,p-DDE (log-trans-
formed ng/g lipid) on FPG and HbA1c at the second follow-up visit, no
associations were observed in either controls or cases in both un-
adjusted and adjusted models (data not shown). Finally, in the ex-
ploratory analysis comparing p,p-DDE levels between cases with
(n= 8) and without chronic kidney disease (n=185), we found that
75.0% of cases with chronic kidney disease had p,p-DDE levels in the
highest quartile compared to 37.8% of cases without chronic kidney
disease.
4. Discussion
In this study of adults living in urban India, levels of p,p-DDE were
high, especially in Delhi where the geometric mean concentration was
579 (95% CI: 521, 643) ng/g lipid compared to 268 (95% CI: 217, 332)
ng/g lipid among adults the United States (most recent estimate, for
2003–2004) (Centers for Disease Control and Prevention, 2019). Male
sex, employment, high monthly household income, and use of tobacco
were predictive of higher plasma levels of p,p-DDE. Although the point
estimate for the association of p,p-DDE with incident diabetes after
adjustment for confounders, namely city and sex (matching factors),
age, waist circumference (a proxy for central adiposity), and FPG, was
compatible with a null finding, the 95% CI was wide, ranging from 0.30
to 2.55. As this is the first study to evaluate the association between
plasma p,p-DDE concentration and incident type 2 diabetes in India,
where the obesity transition is still in the early stages, more studies are
needed to inform our understanding of the association in this context.
These should include systematic studies of routes of exposure given the
large difference in concentration observed between Delhi and Chennai.
While few previous studies have reported blood levels of p,p-DDE in
India (Dhananjayan et al., 2012; Bhatnagar et al., 2004; Subramaniam
and Solomon, 2006), the high levels of p,p-DDE found in Delhi in this
study were not surprising considering that the National Vector Borne
Disease Control Programme continues to recommend indoor residual
spraying of households with DDT (the parent compound) for the control
of malaria, visceral leishmaniasis, and other vector-borne diseases
(Directorate General of Health Services, 2019). Since 2008, when China
discontinued production, India has been the only country still produ-
cing DDT (Van Den Berg et al., 2017), and between 2000 and 2009,
India accounted for 82% of global use of DDT for vector control, ap-
plying 3623 metric tons of DDT compared to 805 metric tons applied
Table 1
Baseline characteristics of type 2 diabetes cases and controls living in urban
India.
Cases
(n= 193)
Controls
(n=323)
Citya
Chennai, % (n) 46.1 (89) 55.1 (178)
Delhi, % (n) 53.9 (104) 44.9 (145)
Sexa
Female, % (n) 56.5 (109) 57.3 (185)
Male, % (n) 43.5 (84) 42.7 (138)
Age (years) 43.7 ± 11.7 35.9 ± 10.4
Educational attainment
No schooling up to primary school 21.2 (41) 17.0 (55)
High school up to secondary school 63.2 (122) 66.3 (214)
Graduate level or higher 15.5 (30) 16.7 (54)
Occupational status, % (n)
Not working 57.0 (110) 52.3 (169)
Unskilled/semi-skilled 20.2 (39) 22.6 (73)
Trained/skilled or white collar 22.8 (44) 25.1 (81)
Monthly household income, % (n)
≤10,000 INR (~$140 USD) 70.0 (135) 79.6 (257)
>10,000 and ≤ 20,000 INR 18.1 (35) 10.5 (34)
>20,000 INR (~$280 USD) 11.9 (23) 9.9 (32)
Family history of diabetes, % yes (n) 31.1 (60) 22.0 (71)
Ever use tobacco products, % yes (n) 25.4 (49) 21.1 (68)
Ever consume alcohol, % yes (n) 17.1 (33) 19.2 (62)
Vegetarian, % yes (n)b 22.8 (44) 18.3 (59)
Vegan, % yes (n)b 2.1 (4) 3.7 (12)
Meat intake (times/day) 0.13 ± 0.21 0.12 ± 0.25
Poultry intake (times/day) 0.12 ± 0.14 0.12 ± 0.14
Seafood intake (times/day) 0.15 ± 0.23 0.17 ± 0.22
Egg intake (times/day) 0.30 ± 0.37 0.31 ± 0.39
Dairy intake (times/day) 0.50 ± 0.52 0.49 ± 0.54
Vegetable intake (times/day) 1.65 ± 1.02 1.76 ± 1.84
Fruit intake (times/day) 0.57 ± 0.63 0.48 ± 0.52
Legume intake (times/day) 0.47 ± 0.40 0.52 ± 1.57
Nut intake (times/day) 0.13 ± 0.28 0.09 ± 0.22
Whole grain intake (times/day) 0.62 ± 0.90 0.57 ± 0.72
Refined grain intake (times/day) 1.38 ± 1.20 1.82 ± 1.99
Fried food intake (times/day) 0.18 ± 0.29 0.21 ± 0.34
Desserts intake (times/day) 0.34 ± 0.48 0.33 ± 0.44
p,p-DDE (ng/g lipid) 615.0 ± 827.8 454.9 ± 665.3
BMI (kg/m2) 27.5 ± 5.0 23.4 ± 4.5
BMI status
Normal weight (BMI <25 kg/m2) 29.5 (51) 66.4 (194)
Overweight (BMI 25 - < 30 kg/m2) 41.6 (72) 25.3 (74)
Obesity (BMI ≥30 kg/m2) 28.9 (50) 8.2 (24)
Waist circumference (cm) 90.4 ± 11.4 79.6 ± 11.4
Fasting blood glucose (mg/dl) 102.8 ± 10.7 89.4 ± 6.1
HbA1c (%) 6.0 ± 0.4 5.3 ± 0.3
Chronic kidney disease, % yes (n)c 4.2 (8) 2.5 (8)
Values are mean ± SD or % (n). Abbreviations: BMI, body mass index; DDE,
dichlorodiphenyldichloroethylene.
a Matching factors.
b Vegetarian diets defined as eating meat, poultry, and seafood never or less
than once a month. Vegan diets defined as eating meat, poultry, seafood, eggs,
and dairy never or less than once a month.
c Defined as an albumin-to-creatinine ratio ≥30mg/g or estimated glo-
merular filtration rate< 60ml/min/1.73m2 at baseline or the second or fourth
follow-up visits.
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across all of Africa (van den Berg, 2011). Previous studies of blood le-
vels of p,p-DDE in India have been small convenience samples from
Madurai (n=22) (Subramaniam and Solomon, 2006), Ahmedabad
(n=18) (Bhatnagar et al., 2004), and Bangalore (n= 30)
(Dhananjayan et al., 2012). The most recent (2012) and strongest (in
terms of laboratory analytical technique) of these studies, in Bangalore,
found that 80% of samples had detectable levels of p,p-DDE with a
mean level of 5.67 μg/l (neither blood lipid-adjusted values nor geo-
metric mean values were reported) (Dhananjayan et al., 2012). A recent
study of South Asians living in the United Kingdom reported a median
concentration of p,p-DDE>8-fold higher than European whites, de-
spite having lived outside South Asia for an average of 16 years: median
of 535.87 ng/g lipid (range: 26.82 to 25,143.8 ng/g lipid) versus
61.26 ng/g lipid (range: 17.65 to 353.3 ng/g lipid) (Daniels et al.,
2018). The median value reported in that study (535.87 ng/g lipid) is
strikingly similar to the geometric mean value observed in Delhi in our
study (579 ng/g lipid), but much higher than that in Chennai (geo-
metric mean of 122 ng/g lipid).
In addition to the use of DDT for vector control, diet is likely to be
another important exposure pathway. Several recent studies in northern
India (in the state of Punjab, near to Delhi) have reported p,p-DDE is
one of the most frequently detected residues in high-fat animal-based
products such as milk and ghee (clarified butter) (Bedi et al., 2015; Bedi
et al., 2016). This may at least partially explain the higher levels of p,p-
DDE among adults living in Delhi versus Chennai as dairy and ghee
consumption are higher in northern India versus southern India. Sup-
porting this hypothesis, we observed higher dairy intake levels among
participants in quartile 2 of p,p-DDE compared to those in quartile 1
(referent). More research is needed to understand specific routes of
dietary exposure to p,p-DDE and other persistent organic pollutants in
the context of India to inform recommendations for those wishing to
reduce their exposure to these potential EDCs.
Table 2
Association of sociodemographic and clinical characteristics with p,p-DDE concentration among controls (n=323) living in urban India.
Quartile of p,p-DDE
1
(n= 81)
2
(n= 80)
3
(n= 82)
4
(n= 80)
P-value⁎
City < 0.0001
Chennai, % (n) 90.1 (73) 75.0 (60) 41.5 (34) 13.8 (11)
Delhi, % (n) 9.9 (8) 25.0 (20) 58.5 (48) 86.3 (69)
Sex < 0.0001
Female, % (n) 77.8 (63) 65.0 (52) 54.9 (45) 31.3 (25)
Male, % (n) 22.2 (18) 35.0 (28) 45.1 (37) 68.8 (55)
Age (years) 32.6 ± 8.3 35.0 ± 9.2 36.6 ± 9.7 39.5 ± 12.7 0.0003
Educational attainment 0.19
No schooling up to primary school 17.3 (14) 21.3 (17) 13.4 (11) 16.3 (13)
High school up to secondary school 72.8 (59) 62.5 (50) 70.7 (58) 58.8 (47)
Graduate level or higher 9.9 (8) 16.3 (13) 15.9 (13) 25.0 (20)
Occupational status, % (n) 0.002
Not working 66.7 (54) 56.3 (45) 52.4 (43) 33.8 (27)
Unskilled/semi-skilled 21.0 (17) 20.0 (16) 18.3 (15) 31.3 (25)
Trained/skilled or white collar 12.4 (10) 23.8 (19) 29.3 (24) 35.0 (28)
Monthly household income, % (n) < 0.0001
≤10,000 INR (~$140 USD) 91.4 (74) 78.8 (63) 78.1 (64) 70.0 (56)
>10,000 and ≤ 20,000 INR 8.6 (7) 17.5 (14) 6.1 (5) 10.0 (8)
>20,000 INR (~$280 USD) 0.0 (0) 3.8 (3) 15.9 (13) 20.0 (16)
Family history of diabetes, % yes (n) 28.4 (23) 25.0 (20) 17.1 (14) 17.5 (14) 0.22
Ever use tobacco products, % yes (n) 12.4 (10) 16.3 (13) 24.4 (20) 31.3 (25) 0.02
Ever consume alcohol, % yes (n) 13.6 (11) 15.0 (12) 23.2 (19) 25.0 (20) 0.16
BMI (kg/m2) 23.7 ± 4.5 24.3 ± 5.4 22.6 ± 4.0 23.1 ± 3.9 0.36
BMI status 0.03
Normal weight (BMI <25 kg/m2) 59.2 (42) 63.5 (47) 75.7 (56) 67.1 (49)
Overweight (BMI 25 - < 30 kg/m2) 33.8 (24) 20.3 (15) 18.9 (14) 28.8 (21)
Obesity (BMI ≥30 kg/m2) 7.0 (5) 16.2 (12) 5.4 (4) 4.1 (3)
Waist circumference (cm) 76.8 ± 10.8 79.7 ± 12.0 79.4 ± 10.9 83.0 ± 11.1 0.02
Fasting blood glucose (mg/dl) 88.9 ± 5.1 87.3 ± 5.9 89.8 ± 6.9 91.6 ± 5.8 < 0.0001
HbA1c (%) 5.30 ± 0.23 5.28 ± 0.31 5.31 ± 0.27 5.19 ± 0.35 0.14
Values are mean ± SD or % (n). Abbreviations: BMI, body mass index; DDE, dichlorodiphenyldichloroethylene.
⁎ p-Value from Chi-square test or Kruskal-Wallis.
Table 3
Association of p,p-DDE concentration with type 2 diabetes among adults (n= 516) living in urban India.
Quartile of p,p-DDE
1 2 3 4
Model 1: Unadjusted 1.00 1.13 (0.65, 1.99) 1.08 (0.59, 1.96) 2.30 (1.19, 4.43)
Model 2: Adjusted for sociodemographic characteristicsa 1.00 0.93 (0.43, 1.99) 0.71 (0.36, 1.40) 0.94 (0.51, 1.74)
Model 3: Adjusted for Model 2+waist circumference 1.00 0.69 (0.27, 1.76) 0.72 (0.33, 1.56) 0.82 (0.39, 1.72)
Model 4: Adjusted for Model 3+ FPGb 1.00 0.78 (0.20, 3.07) 1.06 (0.34, 3.34) 0.87 (0.30, 2.55)
Values are odds ratio (95% confidence interval) estimated from conditional logistic regression. Abbreviations: DDE, dichlorodiphenyldichloroethylene; FPG, fasting
plasma glucose.
a Specifically, adjusted for age (years), occupational status (not working, unskilled/semi-skilled, or trained/skilled/white collar), monthly household income
(≤10,000 INR, 10,000 – ≤20,000 INR, or> 20,000 INR), and ever use tobacco products (yes or no).
b Parameter estimates for all covariates provided in Supplementary Materials, p. 4.
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Given that the half-life of p,p-DDE in blood is estimated to be 6 to
7 years (Ritter et al., 2009), the widespread application of DDT in India
is likely to have long-term implications on human exposure levels. The
persistence of p,p-DDE in blood was supported in our study by the
strong positive association we observed between p,p-DDE and age. This
is consistent with many previous studies documenting higher levels of
p,p-DDE and other persistent organic pollutants among older popula-
tions (Zong et al., 2018). However, in contrast to some previous studies
(Zong et al., 2018), we found that ever smoking was associated with
higher p,p-DDE levels. We also found that employment and having a
higher monthly household income were associated with higher con-
centrations of p,p-DDE, which could relate to greater intakes of high-fat
foods, more frequent indoor residual spraying, or some combination of
these and other factors in this setting.
Over the past 2 years, several studies have been published that
evaluate the association between pesticides and diabetes among Asian
populations. Similar to our study, a cross-sectional case-control study
conducted in Phitsanulok Province, Thailand, largely among farmers
(~75% of both physician-diagnosed diabetes cases and neighbor con-
trols matched on sex and age), found no association between self-re-
ported use of DDT (32 [7.1%] of cases and 48 [8.8%] of controls re-
ported ever using DDT): the adjusted OR (95% CI) was 0.83 (0.50, 1.37)
(Juntarawijit and Juntarawijit, 2018). This is similar to our adjusted OR
(95% CI) of 0.87 (0.30, 2.55) comparing the highest and lowest quar-
tiles of plasma p,p-DDE.
In contrast, the aforementioned cross-sectional case-control study
among South Asians living in the United Kingdom found that type 2
diabetes cases (n= 24) were more likely to have plasma levels of p,p-
DDE above the 50th percentile compared to controls matched on sex,
age, proportion of Telugus, smoking status, and waist-hip ratio
(n=96): adjusted OR (95% CI), 7.00 (2.22, 22.06) (Daniels et al.,
2018). This effect estimate is substantially higher than the summary OR
(95% CI) reported in a recent meta-analysis of 14 studies that evaluated
the association between p,p-DDE and diabetes: 1.95 (1.44, 2.66)
(Evangelou et al., 2016). Interestingly, the adjusted OR (95% CI) for
p,p-DDT, which is very similar in terms of chemical structure, was null
in the UK study: 0.8 (0.33, 1.99) (Daniels et al., 2018) whereas the
meta-analysis reported an OR (95% CI) of 1.79 (1.28, 2.49) for p,p-DDT
(Evangelou et al., 2016).
Our findings of a null effect of p,p-DDE levels on incident type 2
diabetes in this population of urban Indian adults is inconsistent with
decades of studies from animal and tissue culture models demonstrating
biological plausibility (Howell III et al., 2014; Pavlikova et al., 2015;
Kelce et al., 1995; Kuiper et al., 1998; La Merrill et al., 2014). Among
controls we found that mean FPG levels were higher among those with
the highest concentration of p,p-DDE: mean FPG of 91.6 mg/dl in the
highest quartile of p,p-DDE compared to 88.9mg/dl in the lowest
quartile. Moreover, it has been posited that as the obesity transition
progresses within populations – and with it, excess adiposity – the re-
tention and toxicity of persistent organic pollutants such as DDT and
DDE as relates to the risk of type 2 diabetes increases (Lee et al., 2006).
The mean BMI among cases in this study was 27.5 kg/m2, which is
lower than that reported in previous prospective nested case-control
studies in the United States: mean baseline BMI among cases of 32.6 kg/
m2 in the Nurses' Health Study II (Zong et al., 2018) and 29.6 kg/m2 in
Coronary Artery Risk Development in Young Adults (CARDIA) (Lee
et al., 2010). The relatively low levels of excess adiposity in our sample
may therefore be another explanation for the observed null effect.
Another explanation may relate to kidney function. A recent cross-
sectional analysis of Mexican Americans in the National Health and
Nutrition Examination Survey found that p,p′-DDE was not associated
with diabetes without nephropathy, but was associated with diabetic
nephropathy (Everett et al., 2017). Given that 95.9% of the incident
type 2 diabetes cases in our sample did not have chronic kidney disease,
our results are similar to that found for diabetes without nephropathy
among Mexican Americans. Also consistent with that previous study,
we found that the few type 2 diabetes cases in our sample that did have
chronic kidney disease were more likely to have the highest levels of
p,p-DDE. These results should be interpreted with caution given the
small sample size (n=8), but do suggest this may be an important
direction for future research.
This study is not without limitations. As with any prospective epi-
demiological study, there may have been residual confounding in our
estimates. In particular, we did not have information on breastfeeding
history or history of weight change, which are thought to influence
blood concentrations of persistent organic pollutants such as DDE and
DDT (Zong et al., 2018; Zong et al., 2016; Milbrath et al., 2009). Our
single-pollutant model is also subject to residual confounding by other
persistent organic pollutants, particularly other organochlorine pesti-
cide metabolites such as beta-hexachlorocyclohexane (parent com-
pound: lindane), which are likely to be highly correlated with p,p-DDE.
Moreover, we only had one measurement of p,p-DDE concentration,
which may not reflect lifetime exposure even for persistent pollutants.
We cannot rule out the possibility of a false negative or type II error,
and we may have been underpowered to detect effect modification by
age. If higher levels of adiposity are associated with greater toxicity of
DDE, then one might predict larger effects among older participants
given well-established changes in body composition that occur as in-
dividuals age (e.g., decreases in muscle mass [sarcopenia] and increases
in body fat) (Borkan and Norris, 1977). The strengths of the study in-
clude its prospective design, relatively large sample size, and direct
measurement of circulating p,p-DDE levels rather than relying on self-
report.
In conclusion, results suggest that levels of p,p′-DDE in Delhi, India
are exceptionally high, and much lower levels were observed in the
southern, coastal city of Chennai. However, we did not observe a sig-
nificant association between p,p-DDE and incident type 2 diabetes in
this sample. As this is the first study to evaluate the association between
plasma p,p-DDE concentration and incident type 2 diabetes in India,
more studies are needed in order to make more definitive conclusions
regarding the diabetogenic potential of this exposure in this context.
Future research should continue to build laboratory capacity for en-
vironmental biomonitoring in India, specifically EDCs given the ever-
growing diabetes epidemic.
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